ArticleCureus2025
Two Cerebrospinal Fluid (CSF) Diversion Procedures for Two Separate CSF Pathologies in a 19-Year-Old Male: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrocephalus is a dynamic neurosurgical entity, with cerebrospinal fluid (CSF) diversion methods continually evolving to strike a balance between long-term efficacy and the risk of complications. We describe a 19-year-old man who was treated with endoscopic third ventriculostomy (ETV) for congenital aqueductal stenosis, with initial relief of symptoms. Two years later, he experienced recurring headaches and papilledema, but neuroimaging showed stable ventricles and patency of the ETV stoma. Magnetic resonance venography (MRV) ruled out venous sinus thrombosis, while lumbar CSF manometry revealed persistently elevated intracranial pressure (ICP), consistent with CSF absorption dysfunction. Given his refractory symptoms despite medical therapy, a lumboperitoneal (LP) shunt was placed, leading to complete resolution of symptoms and papilledema. This case underscores the paradox of post-ETV intracranial hypertension, reinforcing that a patent ETV does not equate to normal CSF dynamics. Integrating continuous ICP monitoring, advanced CSF flow imaging, and personalized diversion strategies may enhance long-term outcomes in this complex subset of hydrocephalus patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.